Capital Introduction, Placement Agent or Investment Bank?

When a US growth-stage issuer decides to raise money in the Gulf, the first call is almost always to an investment bank. It's a habit, and it's often the wrong first move. The choices are actually three: capital introduction, placement agent, or investment banking mandate. Each is a different product with a different cost, reach, and disclosure burden. This piece is about picking between them, and the argument is simple: work backwards from your investor list, not forwards from your target raise size.

We'll walk through why US issuers default to a bank, then break down each route in turn. From there, we'll cover the three criteria that actually decide the matter, mandate size, investor type, and disclosure burden, plus what a Gulf raise still asks of you on the US side. You'll also get a short self-assessment checklist to run before you appoint anyone. If you're raising capital in the Gulf, the route you choose should fall out of the room you're trying to fill, not the size of the cheque you're hoping to write.

Why a US issuer reaches for an investment bank first

Most US teams reach for an investment bank because it's the only route they've watched work. The vocabulary gives it away: bookrunners, syndicate desks, roadshows. It reads as the default, not one of three options.

The catch is the product. Bank mandates are built for large, standardized tickets. Raise at the smaller end of the growth-stage range and the desk math often won't clear the bank's threshold, a floor that varies by firm and deserves a direct question before you engage.

A syndicate desk also allocates across a book it already runs, and a Gulf sovereign wealth fund or family office after a structured, relationship-based allocation rarely makes the priority list.

Gulf coverage compounds it. That coverage is institutional sales aimed at funds, while single family office private offices often sit outside the map entirely. The cost is time: months before both sides spot the mismatch.

Worth saying plainly: in our experience, raising capital in the Gulf is relationship-led rather than marketed, the two behave nothing alike. A process built in four stages, led personally looks nothing like a roadshow.

The investor list comes first, the route comes second

Start the other way round. Before you call a bank, write the allocator list: names, sovereign wealth fund, institutional fund and family office, and three questions against each. Will they take my ticket size? Does my structure fit their mandate? What do they need to see before they commit capital?

The answers pick the route, not the other way around. Capital introduction gets you the meeting (some firms run it as four stages, led personally), a placement agent executes the issuance, and an investment bank runs a syndicated process. Each does something different. None substitutes for another.

Choose by raise size and you usually choose the channel with the biggest marketing budget rather than the one that reaches your list. And a mixed list rarely fits one mandate: a sovereign anchor plus five family offices is two processes, so plan the sequencing or combine them.

This piece argues a position, not a finding. Most guidance on raising capital treats the channel as fixed. Here, the channel is the decision.

Route one: capital introduction

Route one is a mandate to make warm, relationship-led introductions to a specific list of allocators, not the marketing of an offering to a general audience.

It wins on ticket size. A mid-single-digit or lower-double-digit million family office allocation is a genuine outcome for an introducer and a rounding error for a syndicate desk. That is also who it reaches: single family offices, private offices and sovereign-adjacent vehicles that do not run a public book and never appear on a sales coverage list.

Scope the mandate before you sign it: who owns the relationship, who handles the first diligence requests, what happens after the introduction, and whether follow-on advisory is included.

Relationship-led does not mean diligence-light. FINRA's December 2025 oversight report flags overreliance on prior issuer relationships, failure to address red flags and failure to evidence diligence as recurring private placement weaknesses.

Best fit: in practice (this is a working rule of thumb, not a published benchmark), roughly 10 to 25 named allocators, a structured but not syndicated raise, and a founder-led story that needs a warm door rather than a broadcast.

Route two: placement agent

Where capital introduction opens the door, a placement agent builds the room behind it. You engage an agent to design, structure and place an issuance, typically equity, mezzanine or structured credit, with a targeted investor set. What you are buying: structuring input, documentation support, investor targeting, process management and closing. It sits between an introduction mandate and a full bank process, and wins on larger or more complex raises where the structure has to be built and you want a named agent accountable for the placement.

Get fee mechanics on the table early: retainer, success fee or both, and whether the fee tracks the ticket you actually want rather than gross proceeds alone. Cross-border Gulf placements bring AML, KYC and source-of-funds questions, plus documentation ownership. Confirm who owns each before you sign.

If a FINRA member firm is placing your securities in the US, Rules 5122 and 5123 filing and exemption mechanics apply to that firm. The Rule 5123(b) institutional accredited investor exemption does not extend to sales to individual accredited investors.

Next, the banking mandate, and where it genuinely beats both.

Route three: investment banking mandate

Where the placement agent executes against a list, a bank mandate runs a process. The mandate itself is sized to clear the bank's own economics.

Strengths are real: large tickets, standardized process, institutional sales reach, and a recognizable name that helps price discovery in a competitive round. So are the constraints: there are typically minimum mandate thresholds, confirm the floor directly with the desk, and allocations in a marketed book tend to follow institutional check sizes.

Gulf coverage in a bank process is discussed in Criterion two, confirm which specific allocators your desk has reached before engaging.

Best fit: a raise big enough to justify a syndicated process, with investors who expect bank-led marketing.

Ask the desk two things: which Gulf allocators it has active relationships with, and whether your ticket sits above or below its floor. When the answers are vague, discuss the mandate structure before signing, or discuss how much disclosure your board will accept.

The three criteria that decide the route

Three filters decide whether a route fits: mandate size, investor type and disclosure burden.

Mandate size starts with a floor and a ceiling. What is the smallest ticket you and the allocator can both work with, and the largest single allocation you will take from one investor?

Then investor type. A sovereign wealth fund, an institutional fund, a family office and a private office each run a different process at a different pace, and each expects something different from you.

Finally, disclosure burden: how much of the business, the cap table, the use of proceeds and the customer mix you are willing to expose to run a marketed process.

Use all three together, and score each candidate route against all three before you sign a mandate. The next three sections take one criterion at a time.

Criterion one: mandate size

Two numbers frame this: the smallest ticket worth your time, and the largest allocation you'll accept from one investor. Concentration bites at growth stage, so a big check can come with strings.

Introducers work below a bank's floor. If your target tickets sit in the $5m to $25m band (illustrative, not a published benchmark), in our experience a capital introduction mandate often reaches more of your list per unit of effort in that band, but test this against your specific list. Placement agents sit in the middle, carrying a blended book of a few larger allocations and several smaller ones.

Ask every channel the same question, same words: what's the smallest ticket you'll take to an allocator, and how does your fee look on it?

Then match the route to the shape of the round, not the headline number. A round built from several mid-sized allocations and one large anchor needs a different process than one built from allocations of uniform size.

Criterion two: investor type

If ticket size sets the floor, investor type sets the door. In our experience, a sovereign wealth fund runs a formal, documented process and expects scale, governance and often a strategic angle; it can anchor a round, but it moves slowly. A family office is relationship-led, quicker to a first meeting, often decisive at smaller tickets, with diligence that's founder-and-trust heavy rather than committee heavy. Institutional funds and private equity funds want fit with an existing strategy and a clear path to their return target.

Different types reward different channels. Single family offices often fall outside standard institutional sales coverage, worth confirming with any bank you engage. So build your list by investor type first, then map each type to the channel that actually reaches it. Not the other way round. Disclosure burden is the third filter.

Criterion three: disclosure burden

Investor type sets who you're talking to. Disclosure burden sets how much you're willing to show them.

A marketed banking process casts a wider net: more documentation, more parties, and more of your story circulating before a term sheet lands. Relationship-led introductions run quieter, with details shared progressively as an allocator proves interest and fit.

If a FINRA member firm is involved in placing your securities in the US, filing and disclosure expectations land on the US side, so build them into your timeline, not as an afterthought.

Before you pick a route, write down what stays off limits: customer concentration, cap table detail, margin structure. Then confirm the route can work inside that line.

Lower disclosure isn't automatically better. Sovereign wealth funds and larger institutions often expect more documentation and more diligence before they commit capital. Treat it as a trade-off, not a scorecard.

What a Gulf raise still asks of you on the US side

The route sections above flagged specific US-side filing obligations; here's the fuller picture of what lands on you as issuer.

One more thing before you sign. Scope this correctly: FINRA rules govern FINRA member firms, not Gulf investors or the Gulf side of your transaction. Nothing in your raise outline should imply otherwise.

Where a FINRA member firm places your securities in the US, the standard follows the customer. Regulation Best Interest applies to retail customers; FINRA Rule 2111 suitability covers non-retail customers.

Then diligence. Hold yourself to a high standard by tailoring diligence to each offering, running bad actor checks at both issuer and placement agent level, and monitoring changes in use of proceeds.

The Gulf side is a separate question, usually framed around onshore and free zone regimes such as the DFSA and ADGM FSRA. Keep those references general unless you have current primary sources in hand.

A short self-assessment checklist before you appoint anyone

Before you sign anything, run this. It takes an afternoon and saves months.

1. Build the list. One line per allocator: name, ticket size, investor type, likely process. No names, no route.

2. Score the routes. Put capital introduction, placement agent and investment bank side by side against mandate size, investor type and disclosure burden. Any route that fails one column fails later, and later is expensive.

3. Ask all three the same four questions. Which Gulf allocators did you actually reach in the last 24 months? What's your minimum ticket? How does your fee work? Who owns diligence after the introduction?

4. Sequence it. A sovereign anchor plus a relationship-led tail of family offices is not one mandate. One marketed institutional round is not either. Decide the order before you sign.

5. Close the loose ends. Confirm the US-side filing and disclosure obligations attached to your agent, and settle in writing who owns AML and KYC on a cross-border placement.

For context, one firm in this space: SENS Capital Partners, founded 2022 and headquartered in Dubai, works across capital introduction, private placements, cross-border advisory and strategic counsel, with company-reported transaction value to date of over $240 million. Treat that figure as company-provided, not independently verified.

Pick the route from the investor list backwards

Here's the principle worth keeping: the investor list is the first document you write on a Gulf raise, and the mandate is the last. A sovereign wealth fund, an institutional fund and a single family office each imply a different channel, so the list itself tells you which one.

Then ask the bank, the placement agent and the introducer the same questions and compare answers, not brand names. When the list is mixed, sequence the process instead of forcing one mandate to cover it.

Work backwards from the allocators you want, and the right route usually becomes obvious.

Conclusion

SENS Capital Partners, founded in 2022 and based in Dubai, works across capital introduction, private placements, cross-border advisory and strategic counsel. If your investor list is built, the route is ready to discuss.